Concentration labels can be confusing
Mesquita LA, Spiazzi BF, Piccoli GF, Nogara DA, da Natividade GR, Garbin HI, Wayerbacher LF, Wiercinski VM, Baggio VA, Zingano CP, Schwartsmann G, Lopes G, Petrie JR, Colpani V, Gerchman F
Plateaus are metabolic adaptation, not failure
Emerging multi-agonists such as retatrutide (GLP-1/GIP/glucagon triple agonist) and PTT-A (novel unimolecular peptide tetra-agonist targeting GLP-1, GIP, glucagon and amylin receptors) further expand this concept
May improve liver health GLP-1 medications may help improve liver conditions like fatty liver disease (NAFLD) and its more serious form, NASH
On the brand's page, "GLP-1" is used as marketing shorthand for appetite-support positioning - not as a claim that the patch contains prescription GLP-1 drugs